MedTech firm Bioscan Research raises $1 M in seed round for market expansion

Bengaluru-based MedTech firm Bioscan Research, which is leveraging deeptech in optics, electronics, mechanics and software to develop, test, manufacture and commercialise affordable medical devices for early detection of brain injuries non-invasively, has raised $1 million in a seed round led by Unicorn India Ventures.

The funds raised will be strategically deployed for market expansion, additional regulatory approvals, product upgradation and new IP creation.

Incorporated in 2017, by Anupam Lavania and Shilpa Malik, Bioscan Research aims to improve traumatic brain injury patient outcomes via an objective assessment for early detection at a pre-symptomatic phase with the help of machine learning powered NIRS device - CEREBO.

The flagship product CEREBO, is an advanced intra-cranial injury detector designed to assist in managing trauma patients, even in the absence of visible symptoms, ensuring timely intervention within the golden period.

In the last 12 months the company has witnessed 5x growth and is redefining how critical conditions are identified—enabling faster clinical decisions, improved outcomes, and more accessible care worldwide. Over the next 12 months the company’s goal is to grow 3x and plans to expand in India and overseas markets.